Ömer Genç

7PUBLICATIONS
60CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Prognostic Value of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma.

|May 27, 2026
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Jan 28, 2026
Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone.

Bahattin Engin Kaya, Mehmet Zahid Koçak, Oğuzhan Yıldız

|Nov 27, 2025
Comparative Hepatoprotective Effects of Dapagliflozin and Trimetazidine in Diabetic Rats with Doxorubicin-Induced Liver Injury.

Enver Ciftel, Omer Satiroglu, Muhammed Mursel Ogutveren

|Oct 29, 2025
Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib.

Oğuzhan Yıldız, Talat Aykut, Bahattin Engin Kaya

Pageof 2

Frequent Collaborators

6 joint publications

Murat Araz

5 joint publications

Oğuzhan Yıldız

5 joint publications

Talat Aykut

5 joint publications

Mehmet Artaç